A detailed history of Hedges Asset Management LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Hedges Asset Management LLC holds 50,000 shares of AMRX stock, worth $341,000. This represents 0.21% of its overall portfolio holdings.

Number of Shares
50,000
Previous 84,600 40.9%
Holding current value
$341,000
Previous $513,000 40.94%
% of portfolio
0.21%
Previous 0.41%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$5.24 - $6.34 $181,304 - $219,364
-34,600 Reduced 40.9%
50,000 $303,000
Q1 2023

Apr 18, 2023

BUY
$1.27 - $2.7 $43,942 - $93,420
34,600 Added 69.2%
84,600 $117,000
Q4 2022

Feb 03, 2023

SELL
$1.96 - $2.61 $49,000 - $65,250
-25,000 Reduced 33.33%
50,000 $99,000
Q4 2021

Feb 08, 2022

BUY
$3.95 - $5.85 $296,250 - $438,750
75,000 New
75,000 $359,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.03B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Hedges Asset Management LLC Portfolio

Follow Hedges Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hedges Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hedges Asset Management LLC with notifications on news.